Carbiotix, an award winning biotechnology start-up focused on optimizing gut health with soluble fiber (prebiotics), has closed a second pre-seed financing round of 450,000 Euros, bringing the total capital raised to date to 700,000 Euros. Participating in this round are the current owners as well as a local business angel. The funds will be used to expand marketing and sales activities globally, develop corporate channels to market, further develop its core technology, and accelerate therapeutics development activities linked to the company's unique discovery and delivery platform.
"This financing round is based upon a validation of our consumer platform and competitive position going forward. We look forward to growing this platform and ramping up activities especially with regards to therapeutics development", says CEO Kristofer Cook.
The company plans to close its first external seed financing round at the beginning of 2019 to support physical expansion activities in key markets as well as conduct more extensive pre-clinical studies.